Výsledky vyhledávání - Hongming Yu

  • Zobrazuji výsledky 1 - 6 z 6
Upřesnit hledání
  1. 1
    N6-Methyladenosine–Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells’ Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways

    N6-Methyladenosine–Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells’ Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways Autor Jinghan Wang, Hongming Yu, Wei Dong, Cheng Zhang, Mingtai Hu, Wencong Ma, Xiaoqing Jiang, Hengyu Li, Pinghua Yang, Daimin Xiang

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Effect of Intramyocardial Grafting Collagen Scaffold With Mesenchymal Stromal Cells in Patients With Chronic Ischemic Heart Disease

    Effect of Intramyocardial Grafting Collagen Scaffold With Mesenchymal Stromal Cells in Patients With Chronic Ischemic Heart Disease Autor Xiaojun He, Qiang Wang, Yannan Zhao, He Zhang, Bin Wang, Jun Pan, Jie Li, Hongming Yu, Liudi Wang, Jianwu Dai, Dongjin Wang

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex

    Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex Autor Xuxiao He, Li Min, Hongming Yu, Guijun Liu, Ningning Wang, Chunzhao Yin, Qiaochu Tu, Goutham Narla, Yongzhen Tao, Shuqun Cheng, Huiyong Yin

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study

    Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Singl... Autor Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan‐Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shuqun Cheng

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Efficacy and safety of <scp>TACE</scp> combined with lenvatinib and <scp>PD</scp>‐1 inhibitors for unresectable recurrent <scp>HCC</scp>: A multicenter, retrospective study

    Efficacy and safety of <scp>TACE</scp> combined with lenvatinib and <scp>PD</scp>‐1 inhibitors for unresectable recurrent <scp>HCC</scp>: A multicenter, retrospective study Autor Weijun Wang, Zong‐Han Liu, Kang Wang, Hongming Yu, Yuqiang Cheng, Yan‐Jun Xiang, Jin‐Kai Feng, Liping Zhou, Hongkun Zhou, Weiwei Pan, Wei‐Xing Guo, Jie Shi, Shuqun Cheng

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study

    Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A prelim... Autor Kang Wang, Yan‐Jun Xiang, Hongming Yu, Yuqiang Cheng, Zong‐Han Liu, Jing-Ya Zhong, Shuang Feng, Qian‐Zhi Ni, Hongfei Zhu, Weiwei Pan, Jingjing Li, Chao Liang, Hongkun Zhou, Yan Meng, Wan Yee Lau, Shuqun Cheng

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: